Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

BridgeBio launches Eidos Therapeutics to develop AG-10 for TTR amyloidosis

April 28, 2017

FDA approves Brineura to treat CLN2 disease

April 28, 2017

New phase III trial explores use of simvastatin in children with Noonan syndrome

April 28, 2017

Final 24-month data presented from the phase II OLE trial of patisiran

April 27, 2017

FDA agrees on phase III program for inclisiran

April 27, 2017

FDA approves once-monthly Praluent

April 26, 2017

European Commission grants conditional marketing authorization for Natpar

April 26, 2017

ObsEva initiates phase III program for OBE-2109 to treat uterine fibroids

April 26, 2017

Rhythm Pharmaceuticals patents melanocortin MC4 receptor agonists

April 25, 2017

Xoma reports phase II results for X-213 in prolactin inhibition

April 25, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...